Literature DB >> 18077652

Discrimination of herpes simplex virus type 2 strains by nucleotide sequence variations.

Hisatoshi Kaneko1, Takashi Kawana, Ken Ishioka, Eiko Fukushima, Tatsuo Suzutani.   

Abstract

We determined the polymorphous 400-bp regions in UL53, US1, and US4 for the discrimination of herpes simplex virus type 2 (HSV-2) strains. Thirty-six HSV-2 clinical strains could be differentiated into 35 groups using these three regions and into 36 groups by additional analysis of three noncoding regions previously reported as polymorphous.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18077652      PMCID： PMC2238078          DOI： 10.1128/JCM.01615-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Comparison of polymorphism of thymidine kinase gene and restriction fragment length polymorphism of genomic DNA in herpes simplex virus type 1.

Authors:  M Nagamine; T Suzutani; M Saijo; K Hayashi; M Azuma
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Sensitive and rapid detection of herpes simplex virus and varicella-zoster virus DNA by loop-mediated isothermal amplification.

Authors:  Hisatoshi Kaneko; Tomohiro Iida; Koki Aoki; Shigeaki Ohno; Tatsuo Suzutani
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus.

Authors:  A Chiba; T Suzutani; M Saijo; S Koyano; M Azuma
Journal:  Acta Virol       Date:  1998-12       Impact factor: 1.162

4.  Sequence-based methods for identifying epidemiologically linked herpes simplex virus type 2 strains.

Authors:  Emily Toth Martin; David M Koelle; Benjamin Byrd; Meei-Li Huang; Jeffrey Vieira; Lawrence Corey; Anna Wald
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 5.  Restriction endonuclease patterns of herpes simplex virus DNA: application to diagnosis and molecular epidemiology.

Authors:  B Roizman; M Tognon
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

6.  The genome sequence of herpes simplex virus type 2.

Authors:  A Dolan; F E Jamieson; C Cunningham; B C Barnett; D J McGeoch
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping.

Authors:  Vladimir N Loparev; Antonio Gonzalez; Marlene Deleon-Carnes; Graham Tipples; Helmut Fickenscher; Einar G Torfason; D Scott Schmid
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus.

Authors:  H Sakaoka; K Kurita; Y Iida; S Takada; K Umene; Y T Kim; C S Ren; A J Nahmias
Journal:  J Gen Virol       Date:  1994-03       Impact factor: 3.891

9.  An outbreak of herpes simplex virus type 1 in an intensive care nursery.

Authors:  O Hammerberg; J Watts; M Chernesky; I Luchsinger; W Rawls
Journal:  Pediatr Infect Dis       Date:  1983 Jul-Aug

10.  Analysis of genomic polymorphism among herpes simplex virus type 2 isolates from four areas of Japan and three other countries.

Authors:  H Sakaoka; K Kurita; T Gouro; Y Kumamoto; S Sawada; M Ihara; T Kawana
Journal:  J Med Virol       Date:  1995-03       Impact factor: 2.327
View more
  2 in total

1.  Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.

Authors:  Deborah Watson-Jones; Anna Wald; Connie Celum; Jairam Lingappa; Helen A Weiss; John Changalucha; Kathy Baisley; Clare Tanton; Richard J Hayes; Joshua O Marshak; Rula Green Gladden; David M Koelle
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

2.  miRNA-36 inhibits KSHV, EBV, HSV-2 infection of cells via stifling expression of interferon induced transmembrane protein 1 (IFITM1).

Authors:  Hosni A M Hussein; Shaw M Akula
Journal:  Sci Rep       Date:  2017-12-21       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.